|
1
|
White E: Death-defying acts: a meeting
review on apoptosis. Genes Dev. 7:2277–2284. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patel T and Gores GJ: Apoptosis and
hepatobiliary disease. Hepatology. 21:1725–1741. 1995.PubMed/NCBI
|
|
3
|
Eichhorst ST: Modulation of apoptosis as a
target for liver disease. Expert Opin Ther Targets. 9:83–89. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prétet JL, Pelletier L, Bernard B,
Coumes-Marquet S, Kantelip B and Mougin C: Apoptosis participates
to liver damage in HSV induced fulminant hepatitis. Apoptosis.
8:655–663. 2003.PubMed/NCBI
|
|
5
|
Keppler D, Lesch R, Reutter W and Decker
K: Experimental hepatitis induced by d-galactosamine. Exp Mol
Pathol. 9:279–290. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Galanos C, Freudenberg MA and Reutter W:
Galactosamine-induced sensitization to the lethal effects of
endotoxin. Proc Natl Acad Sci USA. 76:5939–5943. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen NT, Banskota AH, Tezuka Y, Le Tran
Q, Nobukawa T, Kurashige Y, Sasahara M and Kadota S:
Hepatoprotective effect of taxiresinol and
(7′R)-7′-hydroxylariciresinol on d-galactosamine and
lipopolysaccharide-induced liver injury in mice. Planta Med.
70:29–33. 2004.PubMed/NCBI
|
|
8
|
Neuman MG: Apoptosis in diseases of the
liver. Crit Rev Clin Lab Sci. 38:109–166. 2001. View Article : Google Scholar
|
|
9
|
Rietschel ET, Kirikae T, Schade FU, Mamat
U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, Di Padova
F, et al: Bacterial endotoxin: molecular relationships of structure
to activity and function. FASEB J. 8:217–225. 1994.PubMed/NCBI
|
|
10
|
Kosai K, Matsumoto K, Funakoshi H and
Nakamura T: Hepatocyte growth factor prevents endotoxin-induced
lethal hepatic failure in mice. Hepatology. 30:151–159. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganey PE and Roth RA: Concurrent
inflammation as a determinant of susceptibility to toxicity from
xenobiotic agents. Toxicology. 169:195–208. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salido GM and Rosado JA: Apoptosis:
Involvement of oxidative stress and intracellular Ca2+
homeostasis. Apoptosis in the Liver. González-Gallego J and Tũnón
MJ: Springer; Spain: pp. 73–92. 2009
|
|
13
|
Yoon JH and Gores GJ: Death
receptor-mediated apoptosis and the liver. J Hepatol. 37:400–410.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Enari M, Sakahira H, Yokoyama H, Okawa K,
Iwamatsu A and Nagata S: A caspase-activated DNase that degrades
DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43–50.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng EH, Kirsch DG, Clem RJ, Ravi R,
Kastan MB, Bedi A, Ueno K and Hardwick JM: Conversion of Bcl-2 to a
Bax-like death effector by caspases. Science. 278:1966–1968. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thornberry NA and Lazebnik Y: Caspases:
enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Woo M, Hakem A, Elia AJ, Hakem R, Duncan
GS, Patterson BJ and Mak TW: In vivo evidence that caspase-3 is
required for Fas-mediated apoptosis of hepatocytes. J Immunol.
163:4909–4916. 1999.PubMed/NCBI
|
|
18
|
Lee KY and Bae SC: TGF-beta-dependent cell
growth arrest and apoptosis. J Biochem Mol Biol. 35:47–53. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perlman P, Schiemann WP, Brooks MW, Lodish
HF and Weinberg RA: TGF-β induced apoptosis is mediated by the
adapter protein Daxx that facilitates JNK activation. Nature Cell
Biol. 3:708–714. 2001.
|
|
20
|
Schuster N and Krieglstein K: Mechanisms
of TGF-beta-mediated apoptosis. Cell Tissue Res. 307:1–14. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramesh S, Wildey GM and Howe PH:
Transforming growth factor beta (TGFbeta)-induced apoptosis: the
rise and fall of Bim. Cell Cycle. 8:11–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sánchez-Capelo A: Dual role for TGF-β1 in
apoptosis. Cytokine Growth Factor Rev. 16:15–34. 2005.
|
|
23
|
Bedda S, Laurent A, Conti F, Chéreau C,
Tran A, Tran-Van Nhieu J, Jaffray P, Soubrane O, Goulvestre C,
Calmus Y, Weill B and Batteux F: Mangafodipir prevents liver injury
induced by acetaminophen in the mouse. J Hepatol. 39:765–772. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuyama H, Nakamura H, Shimahara Y, Araya
S, Kawada N, Yamaoka Y and Yodoi J: Overexpression of thioredoxin
prevents acute hepatitis caused by thioacetamide or
lipopolysaccharide in mice. Hepatology. 37:1015–1025. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shiratori Y, Kawase T, Shiina S, Okano K,
Sugimoto T, Teraoka H, Matano S, Matsumoto K and Kamii K:
Modulation of hepatotoxicity by macrophages in the liver.
Hepatology. 8:815–821. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu HL and Chen RD: Changes in free
radicals, trace elements, and neurophysiological function in rats
with liver damage induced by d-galactosamine. Biol Trace Elem Res.
34:19–25. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quintero A, Pedraza CA, Siendones E, Kamal
ElSaid AM, Colell A, García-Ruiz C, Montero JL, De la Mata M,
Fernández-Checa JC, Miño G and Muntané J: PGE1 protection against
apoptosis induced by d-galactosamine is not related to the
modulation of intracellular free radical production in primary
culture of rat hepatocytes. Free Radic Res. 36:345–355. 2002.
View Article : Google Scholar
|
